Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the stock. Separately, Roth Capital reiterated a “buy” rating on shares of Bio-Path in a research note on Friday, March 17th. Bio-Path Price Performance NASDAQ BPTH opened […]
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note released on Friday. The firm issued a sell rating on the stock. Separately, Roth Capital restated a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Stock Up 4.4 % Shares of NASDAQ BPTH […]
Bio-Path (NASDAQ:BPTH – Get Rating) and RVL Pharmaceuticals (NASDAQ:RVLP – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Profitability This table compares Bio-Path and RVL Pharmaceuticals’ net margins, […]
Equities researchers at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report issued on Thursday. The firm set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Performance Shares of NASDAQ:BPTH opened […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 74,700 shares, a growth of 6.1% from the April 30th total of 70,400 shares. Based on an average daily volume of 29,600 shares, the short-interest ratio is […]